Prudential Financial
INDV icon

Prudential Financial’s Indivior Pharmaceuticals INDV Stock Holding History

Prudential Financial’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Sell
262,336
-23,764
-8% -$862K 0.01% 662
2026
Q1 		$8.72M Buy
286,100
+233,065
+439% +$7.7M 0.01% 677
2025
Q4 		$1.9M Buy
53,035
+37,510
+242% +$1.15M ﹤0.01% 1338
2025
Q3 		$374K Buy
15,525
+1,455
+10% +$30.4K ﹤0.01% 2038
2025
Q2 		$207K Buy
+14,070
New +$164K ﹤0.01% 2199

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prudential Financial's INDV Position: Q2 2026 in Review

Prudential Financial reduced its Indivior Pharmaceuticals (INDV) stake by 8.3% in Q2 2026, selling an estimated $862K and leaving 262,336 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #662.

Prudential Financial first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Prudential Financial held 262,336 shares of Indivior Pharmaceuticals worth $10.8M as of Q2 2026.
  • Prudential Financial sold 23,764 Indivior Pharmaceuticals shares in Q2 2026, an estimated $862K.
  • Indivior Pharmaceuticals made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #662 holding.
  • Prudential Financial first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.